UroGen Pharma (URGN): Short Seller Sentiment is Bearish On This ADR Stock

UroGen Pharma (URGN): Short Seller Sentiment is Bearish On This ADR Stock

The article discusses the impact of ADR stocks on foreign companies, particularly UroGen Pharma (NASDAQ:URGN), in the U.S. market. Despite challenges, ADRs facilitate investment opportunities for American investors.

Read More

Did you find this insightful?